Amneal gains FDA approval for dementia and oncology drugs
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...
FDA bans Red 3 dye from food and drugs – a scientist explains the artificial color’s health risks and long history
However, mounting scientific evidence suggests that consuming Red 3 poses significant health risks. These risks prompted California to ban its use in food in 2023 and the Food and Drug Administration ...
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
FDA approves nasal spray for treatment-resistant depression
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
WebMD21h
FDA Approves New Treatment for Advanced Breast Cancer
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Healio22h
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
Mint15d
Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade
The company informed investors through an exchange filing on Monday that its subsidiary, Biocon Biologics, has received approval from the Japanese drug authority for a drug used in the treatment ...
Pharmaceutical Technology18d
Drug for Unspecified Dermatological Disorders by TBT Pharma for Unspecified Dermatological Disorders: Likelihood of Approval
GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will ...
Benzinga.com20d
GSK's Sinus Disease Drug Secures Approval In China
The FDA approved Nucala for the same indication in ... Also Read: GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market – Here's Why People with CRSwNP experience ...